INTERNATIONAL PATENT: ATOSSA THERAPEUTICS, INC. FILES APPLICATION FOR "ORAL FORMULATIONS OF (Z)-ENDOXIFEN AND METHODS OF USE THEREOF"

GENEVA, July 3 -- ATOSSA THERAPEUTICS, INC. (10202 5th Avenue NE, Suite 200Seattle, Washington 98125) filed a patent application (PCT/US2024/060830) for "ORAL FORMULATIONS OF (Z)-ENDOXIFEN AND METHODS OF USE THEREOF" on Dec 18, 2024. With publication no. WO/2025/137145, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): QUAY, Steven Carl (c/o Atossa Therapeutics, Inc.10202 5th Avenue NE, Suite 200Seattle, Washington 98125)

Abstract: The present disclosure provides oral formulations comprising (Z)-endoxifen particles and m...